Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease.

Publication ,  Journal Article
Ma, JP; Robbins, CB; Lee, JM; Soundararajan, S; Stinnett, SS; Agrawal, R; Plassman, BL; Lad, EM; Whitson, H; Grewal, DS; Fekrat, S
Published in: Ophthalmol Retina
July 2022

PURPOSE: To assess the baseline differences and longitudinal rate of change in retinal and choroidal imaging parameters between apolipoprotein ε4 (APOE ε4) carriers and noncarriers with normal cognition. DESIGN: Prospective study. SUBJECTS: Four hundred thirteen eyes of 218 individuals with normal cognition aged ≥ 55 years with known APOE status (98 APOE ε4 carriers and 120 noncarriers). The exclusion criteria included diabetes mellitus, uncontrolled hypertension, glaucoma, and vitreoretinal or neurodegenerative disease. METHODS: OCT and OCT angiography (OCTA) were performed at baseline and 2 years (Zeiss Cirrus HD-OCT 5000 with AngioPlex; Zeiss Meditec). The groups were compared using sex- and age-adjusted generalized estimating equations. MAIN OUTCOME MEASURES: OCT parameters: retinal nerve fiber layer thickness, macular ganglion cell-inner plexiform layer thickness, central subfield thickness (CST), and choroidal vascularity index. OCT angiography parameters: foveal avascular zone area, perfusion density (PD), vessel density, peripapillary capillary PD (CPD), and capillary flux index (CFI). The rate of change per year was calculated. RESULTS: At the baseline, the APOE ε4 carriers had lower CST (P = 0.018), PD in the 6-mm ETDRS circle (P = 0.049), and temporal CFI (P = 0.047). Seventy-one APOE ε4 carriers and 78 noncarriers returned at 2 years; at follow-up, the 6-mm ETDRS circle (P = 0.05) and outer ring (P = 0.049) showed lower PD in the APOE ε4 carriers, with no differences in the rates of change between the groups (all P > 0.05). CONCLUSIONS: There was exploratory evidence of differences in the CST, PD, and peripapillary CFI between the APOE ε4 carriers and noncarriers with normal cognition. Larger and longer-term studies may help further elucidate the potential prognostic value of these findings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ophthalmol Retina

DOI

EISSN

2468-6530

Publication Date

July 2022

Volume

6

Issue

7

Start / End Page

607 / 619

Location

United States

Related Subject Headings

  • Retina
  • Prospective Studies
  • Neurodegenerative Diseases
  • Humans
  • Choroid
  • Apolipoprotein E4
  • Alzheimer Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ma, J. P., Robbins, C. B., Lee, J. M., Soundararajan, S., Stinnett, S. S., Agrawal, R., … Fekrat, S. (2022). Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease. Ophthalmol Retina, 6(7), 607–619. https://doi.org/10.1016/j.oret.2022.03.001
Ma, Justin P., Cason B. Robbins, Jia Min Lee, Srinath Soundararajan, Sandra S. Stinnett, Rupesh Agrawal, Brenda L. Plassman, et al. “Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease.Ophthalmol Retina 6, no. 7 (July 2022): 607–19. https://doi.org/10.1016/j.oret.2022.03.001.
Ma JP, Robbins CB, Lee JM, Soundararajan S, Stinnett SS, Agrawal R, et al. Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease. Ophthalmol Retina. 2022 Jul;6(7):607–19.
Ma, Justin P., et al. “Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease.Ophthalmol Retina, vol. 6, no. 7, July 2022, pp. 607–19. Pubmed, doi:10.1016/j.oret.2022.03.001.
Ma JP, Robbins CB, Lee JM, Soundararajan S, Stinnett SS, Agrawal R, Plassman BL, Lad EM, Whitson H, Grewal DS, Fekrat S. Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease. Ophthalmol Retina. 2022 Jul;6(7):607–619.
Journal cover image

Published In

Ophthalmol Retina

DOI

EISSN

2468-6530

Publication Date

July 2022

Volume

6

Issue

7

Start / End Page

607 / 619

Location

United States

Related Subject Headings

  • Retina
  • Prospective Studies
  • Neurodegenerative Diseases
  • Humans
  • Choroid
  • Apolipoprotein E4
  • Alzheimer Disease